Redmile Group’s Keros Therapeutics KROS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.38M | Hold |
552,506
| – | – | 0.79% | 28 |
|
|
2025
Q1 | $5.63M | Hold |
552,506
| – | – | 0.53% | 35 |
|
|
2024
Q4 | $8.75M | Hold |
552,506
| – | – | 0.61% | 35 |
|
|
2024
Q3 | $32.1M | Hold |
552,506
| – | – | 1.89% | 25 |
|
|
2024
Q2 | $25.2M | Hold |
552,506
| – | – | 1.53% | 27 |
|
|
2024
Q1 | $36.6M | Buy |
+552,506
| New | +$36.6M | 1.34% | 29 |
|